Zimmer Biomet Holdings, Inc.

XNYSHealth care

Last traded price · USD

$109.97

+13.30%Market closed

Delayed 15 minutes · Source: ViewTrade · 5 Nov 2026, 06:25 IST · A quote does not mean the product is available to trade on your account.

Day's open: $105.90
Previous close: $97.06
Volume: 6.2M
Day's high: $112.55
Day's low: $101.35

In brief

Zimmer Biomet Holdings, Inc. is a health care company listed on the New York Stock Exchange, valued at about $20.98B.
Its shares closed at $110.15 on 4 Nov 2026, up 6.8% over the past year.
From India you can buy ZBH in US dollars under the RBI's Liberalised Remittance Scheme, including a fraction of one share. See what it costs

Questions investors ask

Can I buy Zimmer Biomet Holdings, Inc. (ZBH) shares from India?

Yes. Indian residents can invest in the US stock market under the Reserve Bank of India's Liberalised Remittance Scheme (LRS), which lets a resident individual remit up to USD 250,000 per financial year, across all permitted purposes combined. US-listed stocks and ETFs are a permitted investment under the LRS. You are solely responsible for ensuring your remittances comply with the LRS annual limit, the applicable Tax Collected at Source (TCS) rules, and all reporting requirements, including Schedule FA in your income-tax return.

Do I need the price of a whole ZBH share to invest?

Yes. You can buy fractional shares, which lets you invest a fixed rupee/dollar amount even in high-priced stocks. For example, if one share trades at USD 1,000 and you invest USD 100, you receive 0.1 of a share.

How much can I invest in US stocks in a year?

Under the LRS, an Indian resident can remit up to USD 250,000 per financial year (April to March) across all permitted purposes combined, from their own funds. This is a per-individual limit set by the RBI.

Can I trade ZBH options or futures?

No. Under RBI / FEMA rules, the LRS does not permit margin trading or speculative instruments such as futures, options, or other derivatives. Your US account is a cash account, not a derivatives and margin account.

Insights

Quotes run fifteen minutes behind.

Set a 52-week high on 4 Nov 2026
Closed at $110.15 on 4 Nov 2026: 2.1% below the 52-week high of $112.55 (4 Nov 2026) and 39.2% above the low of $79.12 (11 May 2026).
Daily price bars, split-adjusted · as of 4 Nov 2026
Rose 13.5% on 4 Nov 2026
The 4 Nov 2026 gain of 13.5% was 9.4× its average daily move of 1.4% over the past year, and its largest one-day gain in a record that begins 26 Oct 2021.
Daily closes, split-adjusted · as of 4 Nov 2026
Behind SPY and its sector fund XLV over 1 year
1 month: +22.8% (SPY −1.6%, XLV +13.5%). 3 months: +12.2% (SPY −0.4%, XLV +15.5%). 1 year: +6.8% (SPY +13.6%, XLV +30.7%). Price change to the 4 Nov 2026 close; dividends excluded.
Daily closes, split-adjusted: ZBH, SPY and XLV · as of 4 Nov 2026
Volume 2.9× its 30-session average on 4 Nov 2026
4 Nov 2026 volume of 6.2M shares was 2.9× the average of the 30 sessions before it (2.1M), as the price rose 13.5%. SPY traded 1.5× its own average that session.
Daily volume against a 30-session baseline · as of 4 Nov 2026
Above its 50- and 200-day averages
The 4 Nov 2026 close of $110.15 was 16.1% above its 50-day average ($94.89) and 19.9% above its 200-day average ($91.84). It has closed above the 200-day for 18 sessions, since 12 Oct 2026. The 50-day average crossed above the 200-day on 13 Aug 2026, 58 sessions ago.
Daily closes, split-adjusted; 50- and 200-session simple averages · as of 4 Nov 2026

Returns

Price return, split-adjusted

At the 4 Nov 2026 close

1 month+22.8%

6 months+33.0%

1 year+6.8%

5 years−20.0%

Newswire

About

Zimmer Biomet designs, manufactures, and markets orthopedic reconstructive implants as well as supplies and surgical equipment for orthopedic surgery. With the acquisitions of Centerpulse in 2003 and Biomet in 2015, Zimmer holds the leading share of the reconstructive market in the United States, Europe, and Japan. Roughly two-thirds of total revenue is derived from sales of large joints; another fourth comes from extremities, trauma, sports medicine, and related surgical products. The firm spun out its dental and spine businesses in 2022.

Website

Notable moves

November 4, 2026
+13.49%
November 5, 2025
−15.15%
May 5, 2025
−11.62%

Zimmer Biomet Holdings, Inc.

XNYSHealth care

Last traded price · USD

$109.97

+13.30%Market closed

Delayed 15 minutes · Source: ViewTrade · 5 Nov 2026, 06:25 IST · A quote does not mean the product is available to trade on your account.

Day's open: $105.90
Previous close: $97.06
Volume: 6.2M
Day's high: $112.55
Day's low: $101.35

In brief

Zimmer Biomet Holdings, Inc. is a health care company listed on the New York Stock Exchange, valued at about $20.98B.
Its shares closed at $110.15 on 4 Nov 2026, up 6.8% over the past year.
From India you can buy ZBH in US dollars under the RBI's Liberalised Remittance Scheme, including a fraction of one share. See what it costs

Questions investors ask

Can I buy Zimmer Biomet Holdings, Inc. (ZBH) shares from India?

Do I need the price of a whole ZBH share to invest?

How much can I invest in US stocks in a year?

Can I trade ZBH options or futures?

Insights

Quotes run fifteen minutes behind.

Set a 52-week high on 4 Nov 2026
Closed at $110.15 on 4 Nov 2026: 2.1% below the 52-week high of $112.55 (4 Nov 2026) and 39.2% above the low of $79.12 (11 May 2026).
Daily price bars, split-adjusted · as of 4 Nov 2026
Rose 13.5% on 4 Nov 2026
The 4 Nov 2026 gain of 13.5% was 9.4× its average daily move of 1.4% over the past year, and its largest one-day gain in a record that begins 26 Oct 2021.
Daily closes, split-adjusted · as of 4 Nov 2026
Behind SPY and its sector fund XLV over 1 year
1 month: +22.8% (SPY −1.6%, XLV +13.5%). 3 months: +12.2% (SPY −0.4%, XLV +15.5%). 1 year: +6.8% (SPY +13.6%, XLV +30.7%). Price change to the 4 Nov 2026 close; dividends excluded.
Daily closes, split-adjusted: ZBH, SPY and XLV · as of 4 Nov 2026
Volume 2.9× its 30-session average on 4 Nov 2026
4 Nov 2026 volume of 6.2M shares was 2.9× the average of the 30 sessions before it (2.1M), as the price rose 13.5%. SPY traded 1.5× its own average that session.
Daily volume against a 30-session baseline · as of 4 Nov 2026
Above its 50- and 200-day averages
The 4 Nov 2026 close of $110.15 was 16.1% above its 50-day average ($94.89) and 19.9% above its 200-day average ($91.84). It has closed above the 200-day for 18 sessions, since 12 Oct 2026. The 50-day average crossed above the 200-day on 13 Aug 2026, 58 sessions ago.
Daily closes, split-adjusted; 50- and 200-session simple averages · as of 4 Nov 2026

Returns

Price return, split-adjusted

At the 4 Nov 2026 close

1 month+22.8%

6 months+33.0%

1 year+6.8%

5 years−20.0%

Newswire

About

Website

Notable moves

November 4, 2026
+13.49%
November 5, 2025
−15.15%
May 5, 2025
−11.62%

Zimmer Biomet Holdings, Inc.

Zimmer Biomet Holdings, Inc. in brief

Set a 52-week high on 4 Nov 2026

Rose 13.5% on 4 Nov 2026

Behind SPY and its sector fund XLV over 1 year

Volume 2.9× its 30-session average on 4 Nov 2026

Above its 50- and 200-day averages

Zimmer Biomet Holdings, Inc.

Zimmer Biomet Holdings, Inc. in brief

Set a 52-week high on 4 Nov 2026

Rose 13.5% on 4 Nov 2026

Behind SPY and its sector fund XLV over 1 year

Volume 2.9× its 30-session average on 4 Nov 2026

Above its 50- and 200-day averages